Omnicell

OMCL · NASDAQ

$36.49+$0.68 (+1.90%)TodayMarket closed · Oct 20, 5:31 PM ET

Prev close $35.81

Latest news

Press releaseOct 8, 4:01 PM ETBusiness Wire
Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026
Press releaseSep 3, 10:00 AM ETPRNewswire
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
Press releaseAug 31, 4:01 PM ETBusiness Wire
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
Press releaseJul 30, 4:01 PM ETBusiness Wire
EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
NewsJul 30, 6:30 AM ET
Omnicell Q2 Adj. EPS $0.94 Beats $0.47 Estimate, Sales $312.208M Beat $310.253M Estimate
Press releaseJul 30, 6:30 AM ETBusiness Wire
Omnicell Announces Second Quarter 2026 Financial Results
Press releaseJul 13, 4:01 PM ETBusiness Wire
Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
Press releaseJul 1, 8:15 AM ETBusiness Wire
Nnamdi Njoku Appointed President of Omnicell
Press releaseJun 8, 8:30 AM ETBusiness Wire
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business
Press releaseJun 2, 4:01 PM ETBusiness Wire
Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
Press releaseMay 4, 4:01 PM ETBusiness Wire
Omnicell to Present at the BofA Securities 2026 Healthcare Conference
Press releaseApr 29, 8:00 AM ETBusiness Wire
Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer
NewsApr 28, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsApr 28, 12:35 PM ETAvi Kapoor
Crude Oil Gains Over 3%; General Motors Earnings Top Views
NewsApr 28, 10:32 AM ET
Omnicell Q1 2026 Earnings Call Transcript
NewsApr 28, 8:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsApr 28, 7:11 AM ET
Earnings Scheduled For April 28, 2026
NewsApr 28, 6:31 AM ET
Omnicell Q1 Adj. EPS $0.55 Beats $0.32 Estimate, Sales $309.880M Beat $303.992M Estimate
Press releaseApr 28, 6:30 AM ETBusiness Wire
Omnicell Announces First Quarter 2026 Financial Results
Press releaseApr 13, 5:00 PM ETBusiness Wire
Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026
Press releaseApr 7, 8:30 AM ETGlobe Newswire
AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
NewsFeb 5, 7:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseFeb 5, 6:30 AM ETBusiness Wire
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results
NewsFeb 5, 6:11 AM ET
Earnings Scheduled For February 5, 2026
Press releaseJan 13, 8:01 AM ETBusiness Wire
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
Press releaseDec 8, 8:00 AM ETBusiness Wire
Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management
Press releaseDec 1, 4:01 PM ETBusiness Wire
Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show
Press releaseNov 20, 4:01 PM ETBusiness Wire
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference
Press releaseNov 13, 8:00 AM ETBusiness Wire
Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies
Press releaseOct 30, 6:30 AM ETBusiness Wire
Omnicell Announces Third Quarter 2025 Financial Results
Press releaseOct 6, 4:01 PM ETBusiness Wire
Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025
Press releaseAug 25, 4:05 PM ETBusiness Wire
Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer
NewsAug 11, 9:02 AM ET
Analyst Expectations For Omnicell's Future
Press releaseJul 31, 6:30 AM ETBusiness Wire
Omnicell Announces Second Quarter 2025 Results
Press releaseJul 14, 4:01 PM ETBusiness Wire
Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025
NewsMay 23, 3:01 PM ET
What Analysts Are Saying About Omnicell Stock
NewsMay 22, 9:12 AM ET
Omnicell Board Approves New $75M Stock Repurchase Program
Press releaseMay 22, 8:30 AM ETBusiness Wire
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations

Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference

EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination

Omnicell Q2 Adj. EPS $0.94 Beats $0.47 Estimate, Sales $312.208M Beat $310.253M Estimate

Omnicell Announces Second Quarter 2026 Financial Results

Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026

Nnamdi Njoku Appointed President of Omnicell

Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business

Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Omnicell to Present at the BofA Securities 2026 Healthcare Conference

Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer

12 Health Care Stocks Moving In Tuesday's Intraday Session

Crude Oil Gains Over 3%; General Motors Earnings Top Views

Omnicell Q1 2026 Earnings Call Transcript

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Earnings Scheduled For April 28, 2026

Omnicell Q1 Adj. EPS $0.55 Beats $0.32 Estimate, Sales $309.880M Beat $303.992M Estimate

Omnicell Announces First Quarter 2026 Financial Results

Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026

AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

Earnings Scheduled For February 5, 2026

Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management

Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show

Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference

Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies

Omnicell Announces Third Quarter 2025 Financial Results

Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025

Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer

Analyst Expectations For Omnicell's Future

Omnicell Announces Second Quarter 2025 Results

Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025

What Analysts Are Saying About Omnicell Stock

Omnicell Board Approves New $75M Stock Repurchase Program

Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program